Literature DB >> 20189150

Slender, older women appear to be more susceptible to nontuberculous mycobacterial lung disease.

Edward D Chan1, Michael D Iseman.   

Abstract

BACKGROUND: Nontuberculous mycobacteria (NTM) are environmental microbes that are associated with a variety of human diseases, particularly chronic lung infections. Over the past several decades, NTM lung disease has been increasingly seen in postmenopausal women with slender body habitus.
OBJECTIVE: This article reviewed the clinical and experimental evidence that supports the observation that thin older women (aged 50-80 years) are predisposed to NTM lung disease. We posited 3 potential pathways for this predisposition: relative estrogen deficiency, abnormal levels of adipokines that alter immune responses, and abnormal expression of transforming growth factor-beta (TGF-beta) related to fibrillin anomalies similar to Marfan syndrome (MFS).
METHODS: Using the PubMed database, a literature search was performed (all publications up to July 2009) by pairing the key phrase nontuberculous mycobacteria with weight, malnutrition, female gender, body habitus, leptin, adipokines, estrogen, menopause, postmenopausal, or body mass index. Non-English-language articles were included if their abstracts were in English. Relevant articles were also identified from the abstracts.
RESULTS: Published case reports and series indicate that in the past 20 years, NTM lung disease has been recognized in disproportionately increased numbers in postmenopausal women. Among these patients, slender body habitus and thoracic cage abnormalities, such as pectus excavatum and scoliosis, are commonly described. Notably, no long-term prospective clinical studies exist to corroborate that low weight is an independent risk factor for NTM lung disease. However, based on the findings of a limited number of experimental studies, we hypothesize that decreased leptin, increased adiponectin, and/or decreased estrogen in older women with slender body habitus may account for their increased susceptibility to NTM infections. We further speculate that in some patients with features mindful of MPS (slender, scoliosis, pectus excavatum, or mitral valve prolapse), there may be anomalies of fibrillin, similar to MFS, that lead to the expression of the immunosuppressive cytokine TGP-beta further increasing their susceptibility to NTM.
CONCLUSIONS: It is likely that both sufficient environmental exposure and host susceptibility are required for the establishment of NTM lung disease. The observation that NTM lung infections are more common in slender, older women without any overt immune defects suggests that abnormal expression of adipokines, sex hormones, and/or TGF-beta may play an important role in their susceptibility. Copyright 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20189150     DOI: 10.1016/j.genm.2010.01.005

Source DB:  PubMed          Journal:  Gend Med        ISSN: 1550-8579


  44 in total

Review 1.  Management of nontuberculous mycobacterial infection in the elderly.

Authors:  Mehdi Mirsaeidi; Maham Farshidpour; Golnaz Ebrahimi; Stefano Aliberti; Joseph O Falkinham
Journal:  Eur J Intern Med       Date:  2014-03-29       Impact factor: 4.487

2.  Long-Term Outcomes in a Population-based Cohort with Respiratory Nontuberculous Mycobacteria Isolation.

Authors:  Emily Henkle; Shannon A Novosad; Sean Shafer; Katrina Hedberg; Sarah A R Siegel; Jennifer Ku; Cara Varley; D Rebecca Prevots; Theodore K Marras; Kevin L Winthrop
Journal:  Ann Am Thorac Soc       Date:  2017-07

3.  Enlarged Dural Sac in Idiopathic Bronchiectasis Implicates Heritable Connective Tissue Gene Variants.

Authors:  M Leigh Anne Daniels; Katherine R Birchard; Jared R Lowe; Michael V Patrone; Peadar G Noone; Michael R Knowles
Journal:  Ann Am Thorac Soc       Date:  2016-10

4.  Patients with nontuberculous mycobacterial lung disease exhibit unique body and immune phenotypes.

Authors:  Marinka Kartalija; Alida R Ovrutsky; Courtney L Bryan; Gregory B Pott; Giamila Fantuzzi; Jacob Thomas; Matthew J Strand; Xiyuan Bai; Preveen Ramamoorthy; Micol S Rothman; Vijaya Nagabhushanam; Michael McDermott; Adrah R Levin; Ashley Frazer-Abel; Patricia C Giclas; Judith Korner; Michael D Iseman; Leland Shapiro; Edward D Chan
Journal:  Am J Respir Crit Care Med       Date:  2012-11-09       Impact factor: 21.405

5.  The Challenge of Pulmonary Nontuberculous Mycobacterial Infection.

Authors:  Shannon Novosad; Emily Henkle; Kevin L Winthrop
Journal:  Curr Pulmonol Rep       Date:  2015-07-12

Review 6.  Exploring immunomodulation by endocrine changes in Lady Windermere syndrome.

Authors:  M R Holt; J J Miles; W J Inder; R M Thomson
Journal:  Clin Exp Immunol       Date:  2019-02-27       Impact factor: 4.330

7.  Changes in cholesterol level correlate with the course of pulmonary nontuberculous mycobacterial disease.

Authors:  Ji Young Hong; Go Eun Yang; Yousang Ko; Yong Bum Park; Yun Su Sim; Sung Hoon Park; Chang Youl Lee; Ki-Suck Jung; Myung Goo Lee
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

8.  Population-based Incidence of Pulmonary Nontuberculous Mycobacterial Disease in Oregon 2007 to 2012.

Authors:  Emily Henkle; Katrina Hedberg; Sean Schafer; Shannon Novosad; Kevin L Winthrop
Journal:  Ann Am Thorac Soc       Date:  2015-05

9.  The impact of low subcutaneous fat in patients with nontuberculous mycobacterial lung disease.

Authors:  Seok Jeong Lee; Yon Ju Ryu; Jin Hwa Lee; Jung Hyun Chang; Sung Shine Shim
Journal:  Lung       Date:  2014-02-19       Impact factor: 2.584

Review 10.  Current Epidemiologic Trends of the Nontuberculous Mycobacteria (NTM).

Authors:  Joseph O Falkinham
Journal:  Curr Environ Health Rep       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.